Veraxa Biotech AG - Post de-SPAC
VRXAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002079109
In the last 90 days, Veraxa Biotech AG - Post de-SPAC insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $992.5K in total; no superinvestor holds it.
Other share classesVRXA
13F holders, Q2 2026
Institutional positions in Veraxa Biotech AG - Post de-SPAC as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +27 vs. Q1 2026
- Shares held
- 8.54M
- +8.54M vs. Q1 2026
- Total value
- $992.5K
- +$992.5K vs. Q1 2026
- New holders
- 27
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRXAW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $992.5K |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Veraxa Biotech AG - Post de-SPAC; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 1 | $0 | 0.00% | +1 | New |
| Longfellow Investment Management Co LLC | 194 | $21 | 0.00% | +194 | New |
| Wolverine Asset Management LLC | 2,917 | $322 | 0.00% | +2,917 | New |
| Susquehanna International Group, LLP | 10,267 | $1.13K | 0.00% | +10,267 | New |
| HRT Financial LP | 25,573 | $2.00K | 0.00% | +25,573 | New |
| Schonfeld Strategic Advisors LLC | 19,892 | $2.19K | 0.00% | +19,892 | New |
| Verition Fund Management LLC | 43,672 | $4.82K | 0.00% | +43,672 | New |
| Berkley W R Corp | 59,990 | $6.62K | 0.00% | +59,990 | New |
| Yakira Capital Management, Inc. | 98,360 | $10.8K | 0.00% | +98,360 | New |
| Context Capital Management, LLC | 100,000 | $11.0K | 0.00% | +100,000 | New |
| Hudson Bay Capital Management LP | 100,000 | $11.0K | 0.00% | +100,000 | New |
| Lineage Point Capital LP | 102,749 | $11.3K | 0.00% | +102,749 | New |
| MMCAP International Inc. SPC | 125,000 | $13.8K | 0.00% | +125,000 | New |
| Shaolin Capital Management LLC | 142,083 | $15.7K | 0.00% | +142,083 | New |
| Tenor Capital Management Co., L.P. | 150,000 | $16.5K | 0.00% | +150,000 | New |
| Westchester Capital Management, LLC | 183,647 | $20.3K | 0.00% | +183,647 | New |
| Wealthspring Capital LLC | 185,330 | $20.4K | 0.00% | +185,330 | New |
| Whitebox Advisors LLC | 193,612 | $21.4K | 0.00% | +193,612 | New |
| BNP Paribas Arbitrage, SA | 253,207 | $27.9K | 0.00% | +253,207 | New |
| JPMorgan Chase & Co | – | $43.8K | 0.00% | – | New |
| Clear Street Group Inc. | 485,358 | $53.5K | 0.00% | +485,358 | New |
| CNH Partners LLC | 658,138 | $72.6K | 0.00% | +658,138 | New |
| Alberta Investment Management Corp | 875,000 | $96.5K | 0.00% | +875,000 | New |
| Aristeia Capital LLC | 976,083 | $115.7K | 0.00% | +976,083 | New |
| Magnetar Financial LLC | 1,055,078 | $116.4K | 0.00% | +1,055,078 | New |
| LMR Partners LLP | 1,089,100 | $120.1K | 0.00% | +1,089,100 | New |
| CSS LLC | 1,600,882 | $176.6K | 0.01% | +1,600,882 | New |